Key Considerations for Differentiated Antiretroviral Therapy Delivery for Specific Populations: Children, Adolescents, Pregnant and Breastfeeding Women and Key Populations
December 31, 2017

Key Considerations for Differentiated Antiretroviral Therapy Delivery for Specific Populations: Children, Adolescents, Pregnant and Breastfeeding Women and Key Populations

The guidance provides the rationale and the approach to expand differentiated ART delivery to populations of people living with HIV who previously may not have been considered “eligible” for ART delivery models for clinically stable clients.

This document provides key considerations on when clinically stable children, adolescents and women who are pregnant or breastfeeding as well as members of key populations (people who inject drugs, sex workers, men who have sex with men, transgender people and people living in prisons and closed settings) can benefit from access to ART services for clinically stable clients, including less frequent clinic visits and multi-month refills for ART and other medications. The guidance provides the rationale and the approach to expand differentiated ART delivery to populations of people living with HIV who previously may not have been considered “eligible” for ART delivery models for clinically stable clients.

Organizations:

World Health Organization (WHO) United States Agency for International Development (USAID) United States President′s Emergency Plan for AIDS Relief (PEPFAR) United States Centers for Disease Control and Prevention (CDC) International AIDS Society (IAS)

Share article: